Malaysian Parliament Successfully Passes GEG Bill

Regulations by 2FIRSTS.ai
Nov.30.2023
Malaysian Parliament Successfully Passes GEG Bill
Malaysia's Parliament successfully passed the Public Health and Tobacco Control Act 2023, which includes a ban on selling tobacco products to minors.

According to a report by Malaysia's national news agency on November 30th, the Malaysian Parliament successfully passed the Public Health and Tobacco Product Control Bill of 2023.

 

Dr. Zaliha Mustafa, the Minister of Health, has proposed a bill that includes provisions to prohibit the sale and purchase of tobacco products, tobacco alternatives, and the provision of any services related to smoking to minors.

 

At the same time, the bill has removed a provision that was established for the Generation Ending Smoking Act (GEG), which prohibited the sale of tobacco products and cigarettes, as well as the smoking of individuals born on or after January 1, 2007.

 

The bill was first introduced on Tuesday (November 28th) and underwent a second reading on November 29th, comprising a total of 54 provisions. It was deliberated by 27 parliament members.

 

Zahliha expressed gratitude to the former Health Minister for researching tobacco issues and drafting legislation.

 

She expressed her gratitude, stating, "They have made efforts to address the general tobacco issue and draft specific bills, for which I (Malaysian Parliament) am deeply grateful.

 

The Malaysia Parliament has also passed the Food (Amendment) Act 2023, which seeks to amend the 1983 Food Act in alignment with the Public Health and Tobacco Control Act 2023.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
South Korea’s Ministry of Food and Drug Safety (MFDS) said it has established its 2026 work plan to systematically manage harmful constituents in tobacco products and disclose related information under the Tobacco Harmfulness Management Act, which took effect in November 2025.
Jan.16 by 2FIRSTS.ai
Azerbaijan Considers Comprehensive Ban on E-cigarettes
Azerbaijan Considers Comprehensive Ban on E-cigarettes
Azerbaijan is advancing legislative amendments to prohibit the circulation of electronic cigarettes and their components. The proposed changes, discussed at a joint meeting of several parliamentary committees, aim to ban the import, export, production, storage, wholesale and retail sale, and use of e-cigarettes.
Dec.17 by 2FIRSTS.ai
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Results from Mexico’s ENCODAT 2025 indicate a structural shift in tobacco and nicotine use: past-month combustible tobacco use among the general population (ages 12–65) declined to 15.1%, down from 17.6% in 2016, while past-month e-cigarette use increased to 2.6%, up from 1.1%.
Dec.25 by 2FIRSTS.ai
China Boton Group Announces Temporary Trading Halt Pending Major Disposal Announcement
China Boton Group Announces Temporary Trading Halt Pending Major Disposal Announcement
China Boton Group Company Limited (Stock Code: 3318) announced that trading in its shares on the Hong Kong Stock Exchange (HKEX) was temporarily suspended at 9 a.m. on December 8, 2025. The suspension was requested by the company pending the release of an announcement related to a “very substantial disposal.”
Dec.08 by 2FIRSTS.ai
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts hosted “Decisive 2026” in Shenzhen, bringing together industry perspectives to examine major shifts in the U.S. new tobacco market in 2025 and their global implications. Sessions covered U.S. market dynamics, technical insights from recently PMTA-authorized products, an investor lens on tobacco capital markets, and 2025 news/product highlights. The event underscored a structural shift from “gray business” toward compliance and sustainable growth, expected to become clearer by 2026.
Jan.09